Latest Breaking News On - Total segment - Page 1 : vimarsana.com

Grab Reports First Quarter 2024 Results

16.05.2024 - Revenue grew 24% year-over-year, or 29% on a constant currency basis to $653 millionOn-Demand GMV grew 18% year-over-year, or 21% on a constant currency basis to $4.2 billionOperating Loss improved by $129 million year-over-year to $(75) .

Republic ofPeter oeyBank flexiloanOwners of the companyFinancial servicesGroup first quarterRevenue for financial servicesGroup adjustedGroup mtusExchange commissionChief financial officerNew initiativesFirst quarterOperating cash flowChinese new yearSegment adjusted

Planet Fitness, Inc Announces First Quarter 2024 Results

Planet Fitness, Inc Announces First Quarter 2024 Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

District of columbiaUnited statesPuerto ricoColleen keatingCraig bensonCompany new growth modelHoldings unitsPlanet fitness incExchange commissionHoldings onNational advertising fundPlanet fitnessNew yearInterim chief executiveNew franchisee growth modelQuarter fiscal

Cabot Corp Reports Second Quarter Fiscal 2024 Results

Diluted earnings per share of $1.49 and Adjusted EPS of $1.78 .

United statesSean keohaneCabot corporationExchange commissionPurification solutionsCabot corporation certain itemsCabot presidentChief executive officerReinforcement materialsPerformance chemicalsMiddle eastLooking statementsInvestor dayTotal segmentFree cash flowDiscretionary free cash flow

Emergent BioSolutions Reports First Quarter 2024 Financial

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of.

United statesJoe papaAssal hellmerJosephc papaCompany cantonUs department of defenseCompany camdenDevelopment expensesExchange commissionEmergent biosolutions incFirst quarterNet incomeDiluted shareSegment gross marginSegment adjusted gross marginAnthrax vaccine adsorbed

Emergent BioSolutions Reports First Quarter 2024 Financial Results

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 millionUpdates FY 2024 guidance .

United statesJosephc papaJoe papaAssal hellmerEmergent biosolutions incExchange commissionDevelopment expensesCompany camdenUs department of defenseCompany cantonFirst quarterNet incomeDiluted shareSegment gross marginSegment adjusted gross marginAnthrax vaccine adsorbed